Ad is loading...
RYVFX
Price
$10.98
Change
-$0.12 (-1.08%)
Updated
Nov 15 closing price
VISVX
Price
$49.63
Change
-$0.34 (-0.68%)
Updated
Nov 15 closing price
Ad is loading...

RYVFX vs VISVX

Header iconRYVFX vs VISVX Comparison
Open Charts RYVFX vs VISVXBanner chart's image
Royce Small-Cap Value Service
Price$10.98
Change-$0.12 (-1.08%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index I
Price$49.63
Change-$0.34 (-0.68%)
VolumeN/A
CapitalizationN/A
RYVFX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RYVFX vs. VISVX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYVFX is a Sell and VISVX is a Buy.

FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 57.6B vs. RYVFX (116M). VISVX pays higher dividends than RYVFX: VISVX (1.90) vs RYVFX (0.87). RYVFX was incepted earlier than VISVX: RYVFX (23 years) vs VISVX (27 years). RYVFX is a more actively managed with annual turnover of: 48.00 vs. VISVX (16.00). RYVFX has a lower initial minimum investment than VISVX: RYVFX (2000) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 28.71 vs. RYVFX (13.33). VISVX return over 5 years is better than : 57.32 vs. RYVFX (18.02).
RYVFXVISVXRYVFX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years27 years-
Gain YTD7.12215.43346%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets116M57.6B0%
Annual Yield % from dividends0.871.9046%
Returns for 1 year13.3328.7146%
Returns for 3 years-0.7513.23-6%
Returns for 5 years18.0257.3231%
Returns for 10 years-14.77108.21-14%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DX12.420.04
+0.32%
Dynex Capital
PNR105.920.06
+0.06%
Pentair plc
TGNA17.64-0.47
-2.60%
TEGNA
HCTI1.16-0.04
-3.33%
Healthcare Triangle
ATOS1.28-0.09
-6.57%
Atossa Therapeutics